Listed Products of GLP-1 Receptor Agonists (GLP-1RA) At present, 9 GLP-1 receptor agonist hypoglycemic drugs have been approved for marketing in the world, namely: exenatide, liraglutide, Exenatide extended-release (exenatide ER), albiglutide, dulaglutide , lixisenatide, benaglutide, semaglutide, polyethylene glycol loxenatide injection and oral semaglutide
Common Uses : Vaccines, antibiotics, hormone treatments
both require medical evaluation, contraindication screening, and ongoing monitoring by a qualified healthcare provider
For context on how Indias pricing landscape shifted so quickly, Part 7 of this series covers the cost and access changes following semaglutides 2026 patent expiry in detail
Nursing Mothers Diazepam passes into breast milk